What is the address of DR. F. GORRÉ - CARDIOLOGIE?

The registered office of DR. F. GORRÉ - CARDIOLOGIE is located at Koningin Astridlaan 20, 9000 Gent.

Is DR. F. GORRÉ - CARDIOLOGIE still active?

Yes. According to the CBE (2 November 2026) DR. F. GORRÉ - CARDIOLOGIE is active, legal situation “Normale toestand”, started on 13 September 2019.

Is DR. F. GORRÉ - CARDIOLOGIE registered on Peppol?

Yes, DR. F. GORRÉ - CARDIOLOGIE is registered on the Peppol network with ID 0208:0734414417.

What is the enterprise number of DR. F. GORRÉ - CARDIOLOGIE?

The enterprise number of DR. F. GORRÉ - CARDIOLOGIE is BE0734414417.

When was DR. F. GORRÉ - CARDIOLOGIE founded?

DR. F. GORRÉ - CARDIOLOGIE was founded on 13 September 2019.

Who are the directors of DR. F. GORRÉ - CARDIOLOGIE?

According to the 2025 annual accounts, the directors of DR. F. GORRÉ - CARDIOLOGIE are: Frauke Gorré.

Is DR. F. GORRÉ - CARDIOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 September 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. F. GORRÉ - CARDIOLOGIE make in 2025?

DR. F. GORRÉ - CARDIOLOGIE posted a profit after taxes of € 246,234 in financial year 2025.

What is the revenue of DR. F. GORRÉ - CARDIOLOGIE?

As a small company, DR. F. GORRÉ - CARDIOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 330,424.

DR. F. GORRÉ - CARDIOLOGIE (Private Limited) - Gent

Dossier DR. F. GORRÉ - CARDIOLOGIE, printed on 2 November 2026 from databakkes.be/en/0734414417/dr-f-gorre-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. F. GORRÉ - CARDIOLOGIE from Gent, company number BE0734414417, closed financial year 2025 with a result of € 246,234 after tax. For that financial year DR. F. GORRÉ - CARDIOLOGIE recorded a gross margin of € 330,424 and equity of € 47,234. Compared with financial year 2024, the result moved from € 214,335 to € 246,234. Profitable, and profit is growing. The buffer shrank hard: equity is 71 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Shrank hard

€ 47,234

▼ 71% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 246,234

▲ 15% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 196,934

▲ 15% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 363,921 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 3,110

▲ 139% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,968

▲ 233% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,079

▲ 56% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 211,309 Gross margin 2022: € 211,309 First fiscal year in the series	€ 231,837 Gross margin 2023: € 231,837 ▲ 10% vs 2022 (€ 211,309) Favourable step	€ 323,306 Gross margin 2024: € 323,306 ▲ 39% vs 2023 (€ 231,837) Favourable step	€ 330,424 Gross margin 2025: € 330,424 ▲ 2% vs 2024 (€ 323,306) Favourable step	▲ 2%
Profit after taxes	€ 132,852 Profit after taxes 2022: € 132,852 First fiscal year in the series	€ 146,462 Profit after taxes 2023: € 146,462 ▲ 10% vs 2022 (€ 132,852) Favourable step	€ 214,335 Profit after taxes 2024: € 214,335 ▲ 46% vs 2023 (€ 146,462) Favourable step	€ 246,234 Profit after taxes 2025: € 246,234 ▲ 15% vs 2024 (€ 214,335) Favourable step	▲ 15%
Equity	€ 133,852 Equity 2022: € 133,852 First fiscal year in the series	€ 79,997 Equity 2023: € 79,997 ▼ 40% vs 2022 (€ 133,852) Unfavourable step	€ 164,921 Equity 2024: € 164,921 ▲ 106% vs 2023 (€ 79,997) Favourable step	€ 47,234 Equity 2025: € 47,234 ▼ 71% vs 2024 (€ 164,921) Unfavourable step	▼ 71%
Total debts	€ 100,523 Total debts 2022: € 100,523 First fiscal year in the series	€ 209,110 Total debts 2023: € 209,110 ▲ 108% vs 2022 (€ 100,523) Unfavourable step	€ 49,680 Total debts 2024: € 49,680 ▼ 76% vs 2023 (€ 209,110) Favourable step	€ 173,949 Total debts 2025: € 173,949 ▲ 250% vs 2024 (€ 49,680) Unfavourable step	▲ 250%
Cash	€ 135,198 Cash 2022: € 135,198 First fiscal year in the series	€ 184,139 Cash 2023: € 184,139 ▲ 36% vs 2022 (€ 135,198) Favourable step	€ 171,317 Cash 2024: € 171,317 ▼ 7% vs 2023 (€ 184,139) Unfavourable step	€ 196,934 Cash 2025: € 196,934 ▲ 15% vs 2024 (€ 171,317) Favourable step	▲ 15%
Retained profit	€ 132,852 Retained profit 2022: € 132,852 First fiscal year in the series	€ 78,997 Retained profit 2023: € 78,997 ▼ 41% vs 2022 (€ 132,852) Unfavourable step	€ 163,921 Retained profit 2024: € 163,921 ▲ 108% vs 2023 (€ 78,997) Favourable step	€ 46,234 Retained profit 2025: € 46,234 ▼ 72% vs 2024 (€ 163,921) Unfavourable step	▼ 72%
Dividend	€ 344,346 Dividend 2022: € 344,346 First fiscal year in the series	€ 200,317 Dividend 2023: € 200,317 ▼ 42% vs 2022 (€ 344,346) Unchanged	€ 129,411 Dividend 2024: € 129,411 ▼ 35% vs 2023 (€ 200,317) Unchanged	€ 363,921 Dividend 2025: € 363,921 ▲ 181% vs 2024 (€ 129,411) Unchanged	▲ 181%
Bank debt	€ 66,021 Bank debt 2022: € 66,021 First fiscal year in the series	€ 31,720 Bank debt 2023: € 31,720 ▼ 52% vs 2022 (€ 66,021) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 31,720) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 234,375 Balance sheet total 2022: € 234,375 First fiscal year in the series	€ 289,107 Balance sheet total 2023: € 289,107 ▲ 23% vs 2022 (€ 234,375) Unchanged	€ 214,602 Balance sheet total 2024: € 214,602 ▼ 26% vs 2023 (€ 289,107) Unchanged	€ 221,184 Balance sheet total 2025: € 221,184 ▲ 3% vs 2024 (€ 214,602) Unchanged	▲ 3%

Key figures of DR. F. GORRÉ - CARDIOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. F. GORRÉ - CARDIOLOGIE?

What happened at DR. F. GORRÉ - CARDIOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 246,234 (▲ 15% vs 2024). Source: NBB ↗
Sep 13, 2019 New establishment in Gent. KBO
Sep 13, 2019 Start of the company according to the CBE. KBO

In short

From € 132,852 profit in 2022 to € 246,234 profit in 2025.

Paid € 224,343 in corporate taxes since 2022.

Best year ever: 2025, with € 246,234 profit.

Paid out € 1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Frauke Gorré

DR. F. GORRÉ - CARDIOLOGIE

Behind DR. F. GORRÉ - CARDIOLOGIE is Frauke Gorré.

Directors

According to the 2025 annual accounts

Frauke Gorré

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Koningin Astridlaan 20

9000 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0734.414.417
VAT number: BE 0734.414.417
Registered office: Koningin Astridlaan 20, 9000 Gent
Names & denominations: DR. F. GORRÉ - CARDIOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 13 September 2019
Peppol: Active · Active since 17 Nov 2025

View on CBE Public ↗ Annual accounts (NBB) ↗